icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
Daclatasvir Exposure Does Not Explain Lower Sustained Virologic Response Rates in Cirrhotic Patients With HCV Genotype 3 Following 12 Weeks of Daclatasvir Plus Sofosbuvir Treatment
 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
Eley T, Raybon J, Wang R, Rana K, Huang S-P, Gandhi Y, Cirincione B, LaCreta F, Garimella T
Bristol-Myers Squibb Research and Development, Princeton, NJ

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif